Flow Pharma
Cleveland
About Flow Pharma
Flow Pharma offers a T-Cell based vaccine delivery platform. The vaccine platform has been tested in an HIV vaccine application (Immunity Project program in partnership with Until There’s A Cure) yielding promising results in animals and in human blood. Flow Pharma is now using a similar approach to develop a vaccine for Ebola, Marburg, and triple negative breast cancer. The company received the first breast cancer collaboration agreement at the largest cancer hospital in Saudi Arabia on 5/11/23. Flow Pharma has 10 issued patents in the US, EU, Canada and Australia and 10 published scientific articles can be found here www.flowpharma.com We are based in Cleveland, Ohio and Riyadh, Saudi Arabia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $25.6M
- Last round: Series Unknown (Aug 2024)
- Website: flowpharma.com
- Phone: (925) 708-8000
Industries & Categories
Biotechnology, Delivery, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/flow-pharma-84175 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.